FOLH1 and prostate carcinoma: The pooled specificity of 68Ga-PSMA-11 PET for diagnosing initial lymph node staging of prostate cancer was 0.94 (95% CI: 0.88–0.99), while mpMRI demonstrated an overall specificity of 0.90 (95% CI: 0.79–0.98), as illustrated in Figure 6.